Lasa Supergenerics Ltd

NSE: LASA · BSE: 540702 · Pharmaceuticals & Biotechnology · 15 announcements

Share price: ₹5.32
Market cap: ₹26.65 Cr
Revenue (annual): ₹25.14 Cr
Net profit (annual): ₹-34.09 Cr
P/E (TTM): -1.6×Sector 47.4×
Promoter holding: 53.65%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Management Change 1 Financial Results 1 Board Meeting Outcome 1 Board Meeting Date 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

25 Aug 2026 16:14 IST BSE

Management Change

Lasa Supergenerics Management Change

Mr. Ganesh Potdar has resigned as Additional and Whole-time Director of Lasa Supergenerics Limited, effective August 25, 2026. The company officially notified the exchanges.

Read the filing ↗